Shares in NZX-listed cancer diagnostic company Pacific Edge have fallen about 55% since the lifting of a trading halt today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback